 | • レポートコード：MRC2-11QY04523 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はRNAベース治療薬・ワクチンのグローバル市場について調査・分析したレポートです。種類別（RNAベース治療薬、RNAベースワクチン）市場規模、用途別（腫瘍学、免疫学、眼科、心血管疾患、感染症、遺伝病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別RNAベース治療薬・ワクチンの競争状況、市場シェア ・世界のRNAベース治療薬・ワクチン市場：種類別市場規模 2015年-2020年（RNAベース治療薬、RNAベースワクチン） ・世界のRNAベース治療薬・ワクチン市場：種類別市場規模予測 2021年-2026年（RNAベース治療薬、RNAベースワクチン） ・世界のRNAベース治療薬・ワクチン市場：用途別市場規模 2015年-2020年（腫瘍学、免疫学、眼科、心血管疾患、感染症、遺伝病、その他） ・世界のRNAベース治療薬・ワクチン市場：用途別市場規模予測 2021年-2026年（腫瘍学、免疫学、眼科、心血管疾患、感染症、遺伝病、その他） ・北米のRNAベース治療薬・ワクチン市場分析：米国、カナダ ・ヨーロッパのRNAベース治療薬・ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのRNAベース治療薬・ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のRNAベース治療薬・ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのRNAベース治療薬・ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alnylam Pharmaceuticals、Arbutus Biopharma、Arrowhead Pharmaceuticals、BioNTech、CureVac、Dicerna Pharmaceuticals、Regulus Therapeutics、Marina Biotech、MiRagen Therapeutics、Moderna Therapeutics、Quark Pharmaceuticals、Roche、Sylentis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.
Market Analysis and Insights: Global RNA-Based Therapeutics and Vaccines Market
The global RNA-Based Therapeutics and Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global RNA-Based Therapeutics and Vaccines Scope and Market Size
RNA-Based Therapeutics and Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNA-Based Therapeutics and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis
Market segment by Type, the product can be split into
RNA-Based Therapeutics
RNA-Based Vaccines
Market segment by Application, split into
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
1.4 Market by Type
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 RNA-Based Therapeutics
1.4.3 RNA-Based Vaccines
1.5 Market by Application
1.5.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Immunology
1.5.4 Ophthalmology
1.5.5 Cardiovascular Diseases
1.5.6 Infectious Diseases
1.5.7 Genetic Diseases
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2015-2026)
2.2 Global RNA-Based Therapeutics and Vaccines Growth Trends by Regions
2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 RNA-Based Therapeutics and Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 RNA-Based Therapeutics and Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key RNA-Based Therapeutics and Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top RNA-Based Therapeutics and Vaccines Players by Market Size
3.1.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2015-2020)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio
3.2.1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2019
3.3 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
3.4 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
3.5 Date of Enter into RNA-Based Therapeutics and Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2015-2020)
4.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
5.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
6.2 RNA-Based Therapeutics and Vaccines Key Players in North America (2019-2020)
6.3 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
6.4 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
7 Europe
7.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
7.2 RNA-Based Therapeutics and Vaccines Key Players in Europe (2019-2020)
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
7.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
8 China
8.1 China RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
8.2 RNA-Based Therapeutics and Vaccines Key Players in China (2019-2020)
8.3 China RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
8.4 China RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
9 Japan
9.1 Japan RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
9.2 RNA-Based Therapeutics and Vaccines Key Players in Japan (2019-2020)
9.3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
9.4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
10.2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
11 India
11.1 India RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
11.2 RNA-Based Therapeutics and Vaccines Key Players in India (2019-2020)
11.3 India RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
11.4 India RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)
12.2 RNA-Based Therapeutics and Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)
12.4 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Alnylam Pharmaceuticals
13.1.1 Alnylam Pharmaceuticals Company Details
13.1.2 Alnylam Pharmaceuticals Business Overview
13.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020))
13.1.5 Alnylam Pharmaceuticals Recent Development
13.2 Arbutus Biopharma
13.2.1 Arbutus Biopharma Company Details
13.2.2 Arbutus Biopharma Business Overview
13.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction
13.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.2.5 Arbutus Biopharma Recent Development
13.3 Arrowhead Pharmaceuticals
13.3.1 Arrowhead Pharmaceuticals Company Details
13.3.2 Arrowhead Pharmaceuticals Business Overview
13.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.3.5 Arrowhead Pharmaceuticals Recent Development
13.4 BioNTech
13.4.1 BioNTech Company Details
13.4.2 BioNTech Business Overview
13.4.3 BioNTech RNA-Based Therapeutics and Vaccines Introduction
13.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.4.5 BioNTech Recent Development
13.5 CureVac
13.5.1 CureVac Company Details
13.5.2 CureVac Business Overview
13.5.3 CureVac RNA-Based Therapeutics and Vaccines Introduction
13.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.5.5 CureVac Recent Development
13.6 Dicerna Pharmaceuticals
13.6.1 Dicerna Pharmaceuticals Company Details
13.6.2 Dicerna Pharmaceuticals Business Overview
13.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
13.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.6.5 Dicerna Pharmaceuticals Recent Development
13.7 Regulus Therapeutics
13.7.1 Regulus Therapeutics Company Details
13.7.2 Regulus Therapeutics Business Overview
13.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.7.5 Regulus Therapeutics Recent Development
13.8 Marina Biotech
13.8.1 Marina Biotech Company Details
13.8.2 Marina Biotech Business Overview
13.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction
13.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.8.5 Marina Biotech Recent Development
13.9 MiRagen Therapeutics
13.9.1 MiRagen Therapeutics Company Details
13.9.2 MiRagen Therapeutics Business Overview
13.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.9.5 MiRagen Therapeutics Recent Development
13.10 Moderna Therapeutics
13.10.1 Moderna Therapeutics Company Details
13.10.2 Moderna Therapeutics Business Overview
13.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction
13.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
13.10.5 Moderna Therapeutics Recent Development
13.11 Quark Pharmaceuticals
10.11.1 Quark Pharmaceuticals Company Details
10.11.2 Quark Pharmaceuticals Business Overview
10.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
10.11.4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.11.5 Quark Pharmaceuticals Recent Development
13.12 Roche
10.12.1 Roche Company Details
10.12.2 Roche Business Overview
10.12.3 Roche RNA-Based Therapeutics and Vaccines Introduction
10.12.4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.12.5 Roche Recent Development
13.13 Sylentis
10.13.1 Sylentis Company Details
10.13.2 Sylentis Business Overview
10.13.3 Sylentis RNA-Based Therapeutics and Vaccines Introduction
10.13.4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)
10.13.5 Sylentis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. RNA-Based Therapeutics and Vaccines Key Market Segments
Table 2. Key Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
Table 3. Ranking of Global Top RNA-Based Therapeutics and Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of RNA-Based Therapeutics
Table 6. Key Players of RNA-Based Vaccines
Table 7. Global RNA-Based Therapeutics and Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global RNA-Based Therapeutics and Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global RNA-Based Therapeutics and Vaccines Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global RNA-Based Therapeutics and Vaccines Market Share by Regions (2015-2020)
Table 11. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global RNA-Based Therapeutics and Vaccines Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. RNA-Based Therapeutics and Vaccines Market Growth Strategy
Table 17. Main Points Interviewed from Key RNA-Based Therapeutics and Vaccines Players
Table 18. Global RNA-Based Therapeutics and Vaccines Revenue by Players (2015-2020) (Million US$)
Table 19. Global RNA-Based Therapeutics and Vaccines Market Share by Players (2015-2020)
Table 20. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2019)
Table 21. Global RNA-Based Therapeutics and Vaccines by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
Table 24. Date of Enter into RNA-Based Therapeutics and Vaccines Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 27. Global RNA-Based Therapeutics and Vaccines Market Size Share by Type (2015-2020)
Table 28. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2021-2026)
Table 29. Global RNA-Based Therapeutics and Vaccines Market Size Share by Application (2015-2020)
Table 30. Global RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 31. Global RNA-Based Therapeutics and Vaccines Market Size Share by Application (2021-2026)
Table 32. North America Key Players RNA-Based Therapeutics and Vaccines Revenue (2019-2020) (Million US$)
Table 33. North America Key Players RNA-Based Therapeutics and Vaccines Market Share (2019-2020)
Table 34. North America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 35. North America RNA-Based Therapeutics and Vaccines Market Share by Type (2015-2020)
Table 36. North America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 37. North America RNA-Based Therapeutics and Vaccines Market Share by Application (2015-2020)
Table 38. Europe Key Players RNA-Based Therapeutics and Vaccines Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players RNA-Based Therapeutics and Vaccines Market Share (2019-2020)
Table 40. Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 41. Europe RNA-Based Therapeutics and Vaccines Market Share by Type (2015-2020)
Table 42. Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 43. Europe RNA-Based Therapeutics and Vaccines Market Share by Application (2015-2020)
Table 44. China Key Players RNA-Based Therapeutics and Vaccines Revenue (2019-2020) (Million US$)
Table 45. China Key Players RNA-Based Therapeutics and Vaccines Market Share (2019-2020)
Table 46. China RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 47. China RNA-Based Therapeutics and Vaccines Market Share by Type (2015-2020)
Table 48. China RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 49. China RNA-Based Therapeutics and Vaccines Market Share by Application (2015-2020)
Table 50. Japan Key Players RNA-Based Therapeutics and Vaccines Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players RNA-Based Therapeutics and Vaccines Market Share (2019-2020)
Table 52. Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 53. Japan RNA-Based Therapeutics and Vaccines Market Share by Type (2015-2020)
Table 54. Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 55. Japan RNA-Based Therapeutics and Vaccines Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players RNA-Based Therapeutics and Vaccines Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players RNA-Based Therapeutics and Vaccines Market Share (2019-2020)
Table 58. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia RNA-Based Therapeutics and Vaccines Market Share by Type (2015-2020)
Table 60. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia RNA-Based Therapeutics and Vaccines Market Share by Application (2015-2020)
Table 62. India Key Players RNA-Based Therapeutics and Vaccines Revenue (2019-2020) (Million US$)
Table 63. India Key Players RNA-Based Therapeutics and Vaccines Market Share (2019-2020)
Table 64. India RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 65. India RNA-Based Therapeutics and Vaccines Market Share by Type (2015-2020)
Table 66. India RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 67. India RNA-Based Therapeutics and Vaccines Market Share by Application (2015-2020)
Table 68. Central & South America Key Players RNA-Based Therapeutics and Vaccines Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players RNA-Based Therapeutics and Vaccines Market Share (2019-2020)
Table 70. Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America RNA-Based Therapeutics and Vaccines Market Share by Type (2015-2020)
Table 72. Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America RNA-Based Therapeutics and Vaccines Market Share by Application (2015-2020)
Table 74. Alnylam Pharmaceuticals Company Details
Table 75. Alnylam Pharmaceuticals Business Overview
Table 76. Alnylam Pharmaceuticals Product
Table 77. Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 78. Alnylam Pharmaceuticals Recent Development
Table 79. Arbutus Biopharma Company Details
Table 80. Arbutus Biopharma Business Overview
Table 81. Arbutus Biopharma Product
Table 82. Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 83. Arbutus Biopharma Recent Development
Table 84. Arrowhead Pharmaceuticals Company Details
Table 85. Arrowhead Pharmaceuticals Business Overview
Table 86. Arrowhead Pharmaceuticals Product
Table 87. Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 88. Arrowhead Pharmaceuticals Recent Development
Table 89. BioNTech Company Details
Table 90. BioNTech Business Overview
Table 91. BioNTech Product
Table 92. BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 93. BioNTech Recent Development
Table 94. CureVac Company Details
Table 95. CureVac Business Overview
Table 96. CureVac Product
Table 97. CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 98. CureVac Recent Development
Table 99. Dicerna Pharmaceuticals Company Details
Table 100. Dicerna Pharmaceuticals Business Overview
Table 101. Dicerna Pharmaceuticals Product
Table 102. Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 103. Dicerna Pharmaceuticals Recent Development
Table 104. Regulus Therapeutics Company Details
Table 105. Regulus Therapeutics Business Overview
Table 106. Regulus Therapeutics Product
Table 107. Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 108. Regulus Therapeutics Recent Development
Table 109. Marina Biotech Business Overview
Table 110. Marina Biotech Product
Table 111. Marina Biotech Company Details
Table 112. Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 113. Marina Biotech Recent Development
Table 114. MiRagen Therapeutics Company Details
Table 115. MiRagen Therapeutics Business Overview
Table 116. MiRagen Therapeutics Product
Table 117. MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 118. MiRagen Therapeutics Recent Development
Table 119. Moderna Therapeutics Company Details
Table 120. Moderna Therapeutics Business Overview
Table 121. Moderna Therapeutics Product
Table 122. Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 123. Moderna Therapeutics Recent Development
Table 124. Quark Pharmaceuticals Company Details
Table 125. Quark Pharmaceuticals Business Overview
Table 126. Quark Pharmaceuticals Product
Table 127. Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 128. Quark Pharmaceuticals Recent Development
Table 129. Roche Company Details
Table 130. Roche Business Overview
Table 131. Roche Product
Table 132. Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 133. Roche Recent Development
Table 134. Sylentis Company Details
Table 135. Sylentis Business Overview
Table 136. Sylentis Product
Table 137. Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020) (Million US$)
Table 138. Sylentis Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA-Based Therapeutics and Vaccines Market Share by Type: 2020 VS 2026
Figure 2. RNA-Based Therapeutics Features
Figure 3. RNA-Based Vaccines Features
Figure 4. Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2020 VS 2026
Figure 5. Oncology Case Studies
Figure 6. Immunology Case Studies
Figure 7. Ophthalmology Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Genetic Diseases Case Studies
Figure 11. Others Case Studies
Figure 12. RNA-Based Therapeutics and Vaccines Report Years Considered
Figure 13. Global RNA-Based Therapeutics and Vaccines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global RNA-Based Therapeutics and Vaccines Market Share by Regions: 2020 VS 2026
Figure 15. Global RNA-Based Therapeutics and Vaccines Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global RNA-Based Therapeutics and Vaccines Market Share by Players in 2019
Figure 18. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2019
Figure 19. The Top 10 and 5 Players Market Share by RNA-Based Therapeutics and Vaccines Revenue in 2019
Figure 20. North America RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
mRNA癌ワクチン・治療薬の世界市場（～2026年） mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…- ペプチド心血管治療薬の世界市場（～2026年） Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart diseas…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- エネルギーベース治療の世界市場（～2026年） Energy-based therapeutics involves the use of energy fields. Schools Public Buildings Large Warehouse Complexes Hotels increased demand for aesthetic surgeries. Market Analysis and Insights: Global Energy-based Therapeutics Market The global Energy-based Therapeutics market size is projected to reac…
- ペプチド胃腸障害治療薬の世界市場（～2026年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…